S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention

DC ElementWertSprache
dc.contributor.authorLeiter, Ulrike
dc.contributor.authorHeppt, Markus V.
dc.contributor.authorSteeb, Theresa
dc.contributor.authorAlter, Mareike
dc.contributor.authorAmaral, Teresa
dc.contributor.authorBauer, Andrea
dc.contributor.authorBechara, Falk G.
dc.contributor.authorBecker, Jürgen C.
dc.contributor.authorBreitbart, Eckhard W.
dc.contributor.authorBreuninger, Helmut
dc.contributor.authorDiepgen, Thomas
dc.contributor.authorDirschka, Thomas
dc.contributor.authorEigentler, Thomas
dc.contributor.authorElGammal, A. K. Stephan
dc.contributor.authorFelcht, Moritz
dc.contributor.authorFlaig, Michael J.
dc.contributor.authorFollmann, Markus
dc.contributor.authorFritz, Klaus
dc.contributor.authorGrabbe, Stephan
dc.contributor.authorGreinert, Rüdiger
dc.contributor.authorGutzmer, Ralf
dc.contributor.authorHauschild, Axel
dc.contributor.authorHillen, Uwe
dc.contributor.authorIhrler, Stephan
dc.contributor.authorJohn, Swen Malte
dc.contributor.authorKofler, Lukas
dc.contributor.authorKoelbl, Oliver
dc.contributor.authorKrause-Bergmann, Albrecht
dc.contributor.authorKraywinkel, Klaus
dc.contributor.authorKrohn, Steffen
dc.contributor.authorLanger, Thomas
dc.contributor.authorLoquai, Carmen
dc.contributor.authorLöser, Christoph R.
dc.contributor.authorMohr, Peter
dc.contributor.authorNashan, Dorothée
dc.contributor.authorNothacker, Monika
dc.contributor.authorPfannenberg, Christina
dc.contributor.authorSalavastru, Carmen
dc.contributor.authorSchmitz, Lutz
dc.contributor.authorStockfleth, Eggert
dc.contributor.authorSzeimies, Rolf-Markus
dc.contributor.authorUlrich, Claas
dc.contributor.authorVoelter-Mahlknecht, Susanne
dc.contributor.authorVordermark, Dirk
dc.contributor.authorWeichenthal, Michael
dc.contributor.authorWelzel, Julia
dc.contributor.authorWermker, Kai
dc.contributor.authorWiegand, Susanne
dc.contributor.authorGarbe, Claus
dc.contributor.authorBerking, Carola
dc.date.accessioned2024-01-04T10:28:37Z-
dc.date.available2024-01-04T10:28:37Z-
dc.date.issued2023
dc.identifier.issn1610-0379
dc.identifier.urihttp://osnascholar.ub.uni-osnabrueck.de/handle/unios/72876-
dc.descriptionCited by: 0; All Open Access, Hybrid Gold Open Access
dc.description.abstractActinic keratosis (AK) are common lesions in light-skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence-based framework for clinical decision making, the guideline “actinic keratosis and cutaneous squamous cell carcinoma” was updated and expanded by the topics cutaneous squamous cell carcinoma in situ (Bowen's disease) and actinic cheilitis. The guideline is aimed at dermatologists, general practitioners, ear nose and throat specialists, surgeons, oncologists, radiologists and radiation oncologists in hospitals and office-based settings, as well as other medical specialties, policy makers and insurance funds involved in the diagnosis and treatment of patients with AK and cSCC. A separate guideline exists for patients and their relatives. In this part, we will address aspects relating to epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention. © 2023 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by Wiley-VCH GmbH on behalf of Deutsche Dermatologische Gesellschaft.
dc.language.isoen
dc.publisherJohn Wiley and Sons Inc
dc.relation.ispartofJDDG - Journal of the German Society of Dermatology
dc.subjectAged
dc.subjectBowen's Disease
dc.subjectCarcinoma, Squamous Cell
dc.subjectHumans
dc.subjectKeratosis, Actinic
dc.subjectSkin
dc.subjectSkin Neoplasms
dc.subjectactinic cheilitis
dc.subjectactinic keratosis
dc.subjectadjuvant radiotherapy
dc.subjectadvanced cancer
dc.subjectArticle
dc.subjectBowen disease
dc.subjectcancer classification
dc.subjectcancer diagnosis
dc.subjectcancer epidemiology
dc.subjectcancer palliative therapy
dc.subjectcancer prevention
dc.subjectcancer prognosis
dc.subjectcancer recurrence
dc.subjectcancer staging
dc.subjectcancer surgery
dc.subjectconsensus
dc.subjectdisease surveillance
dc.subjectevidence based practice
dc.subjectfield cancerization
dc.subjectfollow up
dc.subjecthead and neck surgery
dc.subjecthigh risk population
dc.subjecthistopathology
dc.subjecthuman
dc.subjectimmune deficiency
dc.subjectlymph node dissection
dc.subjectmetastasis
dc.subjectnomenclature
dc.subjectnon invasive measurement
dc.subjectnon invasive procedure
dc.subjectoccupational disease
dc.subjectoncogenesis and malignant transformation
dc.subjectphase 1 clinical trial (topic)
dc.subjectphase 2 clinical trial (topic)
dc.subjectpostoperative care
dc.subjectpostoperative radiotherapy
dc.subjectpractice guideline
dc.subjectprimary prevention
dc.subjectprimary tumor
dc.subjectprophylactic lymphadenectomy
dc.subjectprophylactic surgical procedure
dc.subjectrisk factor
dc.subjectsquamous cell skin carcinoma
dc.subjectsystemic therapy
dc.subjectvulnerable population
dc.subjectactinic keratosis
dc.subjectaged
dc.subjectBowen disease
dc.subjectpathology
dc.subjectskin
dc.subjectskin tumor
dc.subjectsquamous cell carcinoma
dc.titleS3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention
dc.typejournal article
dc.identifier.doi10.1111/ddg.15256
dc.identifier.scopus2-s2.0-85174195158
dc.identifier.urlhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85174195158&doi=10.1111%2fddg.15256&partnerID=40&md5=b8130c9bb795f87ca949e3596b3a04d6
dc.description.volume21
dc.description.issue11
dc.description.startpage1422 – 1433
dcterms.isPartOf.abbreviationJDDG J. German Soc. Dermatol.
local.import.remainsaffiliations : Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuernberg, (CCC ER-EMN), Erlangen, Germany; Center of Dermatooncology, University Department of Dermatooncology, Eberhard-Karls-University Tuebingen, Tübingen, Germany; Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum Campus Minden, Minden, Germany; Department of Dermatology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany; Department of Dermatology, Venerology, and Allergology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany; Translational Skin Cancer Research (TSCR), DKTK Essen/Düsseldorf, University Medicine Essen, Essen, Germany; Association of Dermatological Prevention, Buxtehude, Germany; Institute of Clinical Social Medicine, University Heidelberg, Heidelberg, Germany; CentroDerm Wuppertal, Wuppertal, Germany; Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany; Clinic of Dermatology, Hospital Bethesda, Freudenberg, Germany; Department of Dermatosurgery, St. Josefhospital Heidelberg GmbH, Heidelberg, Germany; Department of Dermatology, Venereology und Allergy, University Medicine Mannheim, Mannheim, Germany; Department of Dermatology and Allergy, University Hospital, LMU Munich, München, Germany; German Guideline Program in Oncology, German Cancer Society, Berlin, Germany; Dermatology and Laser Consultation Center, Landau, Germany; Department of Dermatology, Mainz University Medical School, Mainz, Germany; Elbe Clinics Stade Buxtehude GmbH, Medical Center Buxtehude, Buxtehude, Germany; Department of Dermatology, University Hospital Schleswig-Holstein Campus Kiel, Kiel, Germany; Department of Dermatology & Venerology, Vivantes Hospital Neukölln, Berlin, Germany; DERMPATH Muenchen, München, Germany; Department of Dermatology and Environmental Medicine, University of Osnabrueck, Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm) at the University of Osnabrueck, Osnabrück, Germany; Study Center for Dermatosurgery, University Hospital Tuebingen, Eberhard-Karls-University, Tübingen, Germany; Clinic and Polyclinic for Radiooncology, University Medical Center Regensburg, Regensburg, Germany; Clinic for Trauma-, Orthopedics-, and Plastic Surgery, Department for Plastic-, Aesthetic- and Handsurgery, Gütersloh, Germany; Robert Koch-Institute, Berlin, Germany; German Social Accident Insurance (DGUV), Berlin, Germany; Department of Dermatology, Medical Center Bremen-Ost, Bremen, Germany; Skin Hospital, Skin Cancer Center, Ludwigshafen Hospital, Ludwigshafen, Germany; Department of Dermatology, Klinikum Dortmund, Dortmund, Germany; Association of the Scientific Medical Societies in Germany (AWMF), Institute for Medical Knowledge Management, c/o Philipps Universität Marburg, Marburg, Germany; Department of Diagnostic and Interventional Radiology, Eberhard-Karls-University Tuebingen, Tübingen, Germany; Pediatric Dermatology Discipline, Dermato-oncology Research Facility, “Colentina” Clinical Hospital, Bucharest 020125, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania; Department of Dermatology and Allergology, Klinikum Vest GmbH, Recklinghausen, Germany; Dermatologie am Regierungsviertel, Berlin, Germany; Institute of Occupational Medicine, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany; Department of Radiation Oncology, Martin-Luther-University Halle-Wittenberg, Halle/Saale, Germany; Department of Dermatology, University Hospital Augsburg, Augsburg, Germany; Klinikum Osnabrueck, Department for Oral and Maxillofacial Surgery, Plastic and Aesthetic Operations, Osnabrück, Germany; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Leipzig, Leipzig, Germany
local.import.remainscorrespondence_address : U. Leiter; University Department of Dermatooncology, Eberhard-Karls-Universität, Tübingen, Liebermeisterstrasse 25, 72076, Germany; email: ulrike.leiter@med.uni-tuebingen.de
local.import.remainspmid : 37840404
local.import.remainspublication_stage : Final
crisitem.author.orcid0000-0001-5406-9458-
crisitem.author.netidJoSw269-
Zur Kurzanzeige

Seitenaufrufe

1
Letzte Woche
0
Letzter Monat
0
geprüft am 17.05.2024

Google ScholarTM

Prüfen

Altmetric